Poc 20logo 20 1
Pandoraworking

POC Medical Systems Inc.

"POC Medical Systems" has developed a true low cost portable device that can be used in every where in the world to provide affordable breast cancer screening.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Livermore, CA, USA
  • Currency USD
  • Founded May 2013
  • Employees 25
  • Website pocmedicalsystems.com

Company Summary

POC Medical Systems is Point of Care Diagnostics / Screening Medical Device company. The first application which we have developed is for Breast Cancer Screening. We expect to be able to launch our first product in less than 9 months from now. The need for such a device is extremely large and the technology which we have developed is truly disruptive. We expect it will really change how screening is done today and for a price of less than $10.

Team

  • Default avatar
    Richard Turegano
    VP Operations

    Over 25+ years in Scaleup / Operations and QA/ QC / Regulatory. In the past, he has worked with Novartis, Chiron, Medimmune, Actis Biologics among others to set up large GLP/GMP facilities and oversaw manufacturing runs.

  • Default avatar
    Adesh Kumar
    VP Systems Architecture

    15 + years experience in healthcare and IT industry., developing software and systems architecture.

  • Default avatar
    Sanjeev Saxena
    Chairman and CEO

    Experienced Entrepreneur with 22+ years of experience in engineering, sales / marketing and business development for medical device and Biotech companies. CoFounder – Actis Biologics, Telesto Diagnostics, Scanis, Sepragen Corp

  • Default avatar
    Francis Lau
    Manager Assay Development

    Over 10 years Protein Biochemistry, analytical and assay development.

  • Default avatar
    Eugene Louis Burton
    CSO

    Over 30+ years in development of various drugs and diagnostic kits at Genentech, Bayer, Receptor Biologics and most recently as a Industry consultant at DNA Bridges advising various startup and mid-size companies on development and scale up. Dr. Burton was an Associate professor at Rockefeller Institute. At Genentech he headed up the development of drugs like TPA etc. and at Bayer the development of Recombinant Factor VIII.

Advisors

  • Default avatar
    WILSON SONSINI GOODRICH & ROSATI
    Lawyer
    Unconfirmed
    Default avatar
    Marc Madou
    Professor UC Irvine
    Unconfirmed
    Default avatar
    Matt Coleman
    Senior Staff Scientist, LLNL
    Unconfirmed
  • Default avatar
    Sue Preston
    Regulatory Consultant
    Unconfirmed